Microlex e.U

Austria

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade : Oral

Brand Name : Microlex® LCA 60.m

Application : Direct Compression, Granulation

Excipient Details : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Ingredient(s) : Anhydrous Lactose

Dosage Form : Tablet

Grade : Oral

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Anhydrous Lactose

Dosage Form : Tablet

Category : Direct Compression, Granulation

Brand : MICROLEX® LCA 60.M

Applications : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Grade : Oral

Looking for Fosaprepitant? Find Granulation used in Fosaprepitant to address drug delivery challenges on PharmaCompass.

Fosaprepitant

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

16 USDMF

3 JDMF

6 EU WC

12 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers

24 FDA Orange Book

5 Europe

1 Canada

8 Australia

3 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales

1 Nanjing Well Pharmaceutical

3 Actylis

1 BASF

1 DFE Pharma

3 Gangwal Chemicals

7 Kerry

1 Microlex e.U

1 Nanjing Bold Chemical

6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers

6 Parenteral

5 Fillers, Diluents & Binders

3 Topical

3 Co-Processed Excipients

3 Direct Compression

3 Emulsifying Agents

2 Film Formers & Plasticizers

2 Surfactant & Foaming Agents

2 Thickeners and Stabilizers

1 Granulation

1 Rheology Modifiers

1 API Stability Enhancers

DIGITAL CONTENT

31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

3 Finished Drug Prices

MARKET PLACE

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Exclusivities

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

Filters

Fosaprepitant

01

Microlex e.U

Microlex e.U

POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons